Sutro Biopharma
STRO
#9507
Rank
ยฃ57.43 M
Marketcap
ยฃ6.74
Share price
6.01%
Change (1 day)
205.88%
Change (1 year)

Revenue for Sutro Biopharma (STRO)

Revenue in 2025 (TTM): ยฃ78.9 Million

According to Sutro Biopharma's latest financial reports the company's current revenue (TTM ) is ยฃ79.13 Million. In 2024 the company made a revenue of ยฃ49.44 Million a decrease over the revenue in the year 2023 that were of ยฃ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sutro Biopharma from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ78.9 M59.59%
2024 ยฃ49.44 M-59.03%
2023 ยฃ0.12 B115.4%
2022 ยฃ56.01 M22.2%
2021 ยฃ45.84 M46.26%
2020 ยฃ31.34 M-3.83%
2019 ยฃ32.59 M7.68%
2018 ยฃ30.26 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.48 B 507.75%๐Ÿ‡บ๐Ÿ‡ธ USA